Detalhe da pesquisa
1.
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.
J Virol
; 90(13): 5899-5914, 2016 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27053554
2.
Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains.
Proc Natl Acad Sci U S A
; 110(16): 6470-5, 2013 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23536288
3.
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors.
Proc Natl Acad Sci U S A
; 110(45): 18214-9, 2013 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24145434
4.
Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1.
J Virol
; 87(8): 4185-201, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23365441
5.
Chemical synthesis of highly congested gp120 V1V2 N-glycopeptide antigens for potential HIV-1-directed vaccines.
J Am Chem Soc
; 135(35): 13113-20, 2013 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23915436
6.
Eliminating antibody polyreactivity through addition of N-linked glycosylation.
Protein Sci
; 24(6): 1019-30, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25800131
7.
Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16.
Nat Struct Mol Biol
; 20(7): 804-13, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23708607